Skip to content

Does NRS2002, PG-SGA Before and After Chemoradiation for Esophagus Cancer Predict Nutrition Status And Clinical Outcomes?

Study on nutritional status and clinical outcome of patients with esophageal cancer before and after radiotherapy and chemotherapy.

Status
Recruiting
Phases
Phase 2
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OIC-16010096
Enrollment
Unknown
Registered
2016-12-07
Start date
2016-12-28
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagus cancer

Interventions

Case series:Chemoradiation

Sponsors

Affiliated hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. By pathological or cytological diagnosis of esophageal cancer patients; 2. Signed informed consent; 3. No radiotherapy, chemotherapy contraindications, and received chemotherapy; 4. Aged 18 to 80 years, physical condition score (ECOG 0 ~ 2 or KPS = 70); 5. Patients had good adherence to treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients who did not meet the criteria for pathology classification, staging, and survival status; 2. Not willing to accept chemotherapy patients; 3. Patients with uncontrolled hypertension, diabetes, unstable angina, history of myocardial infarction, or symptomatic congestive heart failure or uncontrolled arrhythmia during the last 12 months, disease activity in bacterial, fungal or viral infections, mental disorders; severe pulmonary dysfunction. 4. Pregnancy or breast-feeding patients; 5. Patients with a history of active malignancy other than esophageal cancer before inclusion, non-melanoma skin basal cell carcinoma, in situ cervical cancer, cured early prostate cancer; 6. With allergies and in patients with known or suspected allergy to any study drug without alternative medicines; 7. Poor compliance in patients; 8. The researchers believe that patients inadequacy participate in this trial.

Design outcomes

Primary

MeasureTime frame
survival time;NRS;PG-SGA;treatment effect;

Countries

China

Contacts

Public ContactHu Ma

Affiliated hospital of Zunyi Medical University

mahuab@163.com+86 18166951084

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026